Aripiprazole and Small intestinal obstruction - a phase IV clinical study of FDA data

Summary:

Small intestinal obstruction is reported as a side effect among people who take Aripiprazole (aripiprazole), especially for people who are female, 60+ old, have been taking the drug for 2 - 5 years also take Clozaril, and have Crohn's disease.

The phase IV clinical study analyzes which people have Small intestinal obstruction when taking Aripiprazole. It is created by eHealthMe based on reports of 38,853 people who have side effects when taking Aripiprazole from the FDA, and is updated regularly.

What is Aripiprazole?

Aripiprazole has active ingredients of aripiprazole. It is often used in depression. eHealthMe is studying from 39,143 Aripiprazole users. Check the latest studies of Aripiprazole.

What is Small intestinal obstruction?

Small intestinal obstruction (blockage in small intestine) is found to be associated with 1,036 drugs and 983 conditions by eHealthMe. Check the latest studies of Small intestinal obstruction.



On Jul, 05, 2026

38,853 people reported to have side effects when taking Aripiprazole.
Among them, 30 people (0.08%) have Small intestinal obstruction.

Could Aripiprazole cause Small intestinal obstruction?

Among these 30 people:

How long have people been on Aripiprazole when they have Small intestinal obstruction? *

  • < 1 month: 0.0 %
  • 1 - 6 months: 0.0 %
  • 6 - 12 months: 0.0 %
  • 1 - 2 years: 50 %
  • 2 - 5 years: 50 %
  • 5 - 10 years: 0.0 %
  • 10+ years: 0.0 %

What is the gender of people who have Small intestinal obstruction when taking Aripiprazole? *

  • female: 69.57 %
  • male: 30.43 %

What is the age of people who have Small intestinal obstruction when taking Aripiprazole? *

  • 0-1: 0.0 %
  • 2-9: 0.0 %
  • 10-19: 0.0 %
  • 20-29: 0.0 %
  • 30-39: 26.09 %
  • 40-49: 8.7 %
  • 50-59: 26.09 %
  • 60+: 39.13 %

What are other drugs people take besides Aripiprazole? *

  1. Clozaril: 9 people, 30.00%
  2. Metformin: 8 people, 26.67%
  3. Paracetamol: 7 people, 23.33%
  4. Depakote: 7 people, 23.33%
  5. Anoro Ellipta: 7 people, 23.33%
  6. Gliclazide: 7 people, 23.33%
  7. Inflectra: 6 people, 20.00%
  8. Vyvanse: 6 people, 20.00%
  9. Pantoprazole: 5 people, 16.67%
  10. Levothyroxine Sodium: 4 people, 13.33%

What are other side effects people have besides Small intestinal obstruction? *

  1. Weakness: 10 people, 33.33%
  2. Fatigue (feeling of tiredness): 10 people, 33.33%
  3. Dehydration (dryness resulting from the removal of water): 9 people, 30.00%
  4. Nausea And Vomiting: 9 people, 30.00%
  5. Nausea (feeling of having an urge to vomit): 8 people, 26.67%
  6. Abdominal Adhesions (inflammation of abdomen): 7 people, 23.33%
  7. Haematochezia (passage of stools containing blood): 7 people, 23.33%
  8. Pouchitis (inflammatory bowel disease): 6 people, 20.00%
  9. Drug Level Above Therapeutic: 6 people, 20.00%
  10. Fistula Discharge (discharge from abnormal passage of structure/organ): 6 people, 20.00%

What are the existing conditions these people have? *

  1. Crohn's Disease (a condition that causes inflammation of the gastrointestinal tract): 10 people, 33.33%
  2. Schizophrenia (a mental disorder characterized by a breakdown of thought processes): 9 people, 30.00%
  3. Stress And Anxiety: 2 people, 6.67%
  4. Major Depression (a mood state that goes well beyond temporarily feeling sad or blue. it is a serious medical illness that affects one's thoughts, feelings): 2 people, 6.67%
  5. Cataplexy (loss of muscle tone accompanied by full conscious awareness): 2 people, 6.67%
  6. Insomnia (sleeplessness): 2 people, 6.67%
  7. Drowsiness: 2 people, 6.67%
  8. Wheezing (a high-pitched whistling sound made while you breath): 1 person, 3.33%
  9. Diabetes: 1 person, 3.33%
  10. Ammonia Increased: 1 person, 3.33%

* Approximation only. Some reports may have incomplete information.

Do you take Aripiprazole and have Small intestinal obstruction?

- Check whether Small intestinal obstruction is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously



Related studies:

Effectiveness of, long term effects of, and alternative drugs to Aripiprazole:

Small intestinal obstruction treatments and more:

How severe was Small intestinal obstruction and when was it recovered:

Expand to all the drugs that have ingredients of aripiprazole:

Sub-studies by gender and age:

Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Browse all side effects of Aripiprazole:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Small intestinal obstruction:

Browse all the conditions that are associated with Small intestinal obstruction:

Related publications that referenced our studies


How the study uses the data?

The study uses data from the FDA. It is based on aripiprazole (the active ingredients of Aripiprazole) and Aripiprazole (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.



Recent studies on eHealthMe: